<?xml version="1.0" encoding="UTF-8"?>
<p>Extrapulmonary poorly differentiated NEC originates in the gastrointestinal tract, and in gynecological and urological organs as either SCLC or LCNEC, which are both similar to their respective well‐known pulmonary counterparts.
 <xref rid="cas14811-bib-0001" ref-type="ref">
  <sup>1</sup>
 </xref> Extrapulmonary poorly differentiated NEC is a rare disease; its incidence accounts for 10%‐20% of malignant NENs.
 <xref rid="cas14811-bib-0002" ref-type="ref">
  <sup>2</sup>
 </xref>, 
 <xref rid="cas14811-bib-0003" ref-type="ref">
  <sup>3</sup>
 </xref> Extrapulmonary poorly differentiated NEC has aggressive histological features that contribute to its poor prognosis and lethality.
 <xref rid="cas14811-bib-0004" ref-type="ref">
  <sup>4</sup>
 </xref> According to an analysis of 14 732 EPNEC cases from the Surveillance Epidemiology and End Results database, distant metastasis was diagnosed in 69% of patients with NEC, and the 5‐year survival rate for patients with distant metastasis was only 5.7%.
 <xref rid="cas14811-bib-0005" ref-type="ref">
  <sup>5</sup>
 </xref>
</p>
